INCIDENCE, MITIGATION, AND MANAGEMENT OF NEUROLOGIC ADVERSE EVENTS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN CARTITUDE-2
Autor: | Einsele, H, Parekh, S, Madduri, D, Santomasso, B, Pérez-Larraya, JG, Donk, NWV, Arnulf, B, Mateos, M, Braganca, KC, Varsos, H, Carrasco-Alfonso, MJ, Akram, M, Lendvai, N, Jackson, CC, Olyslager, Y, Zudaire, E, Li, C, Geng, D, Jakubowiak, A, Cohen, A |
---|---|
Zdroj: | In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S263-S264 |
Databáze: | ScienceDirect |
Externí odkaz: |